奥普碘铵 | 541-66-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氧戊环
• 中文名称: 奥普碘铵
• 中文别名: 4-(二甲基氨基甲基)-1,3-二氧杂环戊烷甲碘化物
• 英文名称: Oxapropaniumiodid
• 英文别名: Oxapropanium iodide；[1,3]dioxolan-4-ylmethyl-trimethyl-ammonium; iodide；[1,3]Dioxolan-4-ylmethyl-trimethyl-ammonium; Jodid；1,3-dioxolan-4-ylmethyl(trimethyl)azanium;iodide
• CAS: 541-66-2
• 化学式: C₇H₁₆NO₂*I
• 分子量: 273.114
• InChiKey: HQWAEQCLIWVOMF-UHFFFAOYSA-M

物化性质

• 熔点：
  158-160°
• 沸点：
  bp21 68°

计算性质

• 辛醇/水分配系数(LogP)：
  -2.93
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  碘甲烷 、 alkaline earth salt of/the/ methylsulfuric acid 在 乙醇 作用下， 生成 奥普碘铵
  参考文献：
  名称：

  Fourneau; Chantalou, Bulletin de la Societe Chimique de France, 1945, vol. <5> 12, p. 845,858

  摘要：

  DOI：

文献信息

• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• New amino-derivatives of dioxa-cyclopentane
  申请人：RHONE POULENC SA

  公开号：US02445393A1

  公开（公告）日：1948-07-20
• 4-Substituted dioxolanes by chemoselective reactions on glycerol formal
  作者：Jean-Louis Gras、Hervé Dulphy、Christophe Marot、Patrick Rollin

  DOI：10.1016/s0040-4039(00)79343-9

  日期：1993.7

  4-Hydroxmethyl-1,3-dioxolane contained in glycerol formal undergoes chemoselective transformations, which constitute a direct entry to 4-substituted-1,3-dioxolanes.
• Methods and devices for the treatment of ocular conditions
  申请人：deJuan Eugene

  公开号：US20060110428A1

  公开（公告）日：2006-05-25

  Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the following bioactive agent delivery methods (A)-(C): (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more bioactive agents subretinally; and (C) instilling (e.g., injecting or delivering by ocular iontophoresis) one or more bioactive agents into the vitreous humor of the eye.
• METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS
  申请人：deJuan Eugene

  公开号：US20110159073A1

  公开（公告）日：2011-06-30

  Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the following bioactive agent delivery methods (A)-(C): (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more bioactive agents subretinally; and (C) instilling (e.g., injecting or delivering by ocular iontophoresis) one or more bioactive agents into the vitreous humor of the eye.